TEDD Competence Centre - Tissue Engineering for Drug Development and Substance Testing
Education, R&D and networking platform promoting the application of 3D organotypic technologies for therapies development, with the core goal of replacing animal experimentation according to 3Rs (Replacement, Reduction and Refinement) in the long term.
DATE: 14 October 2021
PLACE: ZHAW, Wädenswil, Switzerland
- Ori Bar-Nur, ETHZ Dep. of Health Sciences and Technology
- Olivier Frey, InSphero
- Damien Loterie, Readily3D
- Vincent Revol, CSEM SA
- Laura Suter-Dick, University of Applied Sciences and Arts Northwestern Switzerland FHNW
- Suman Das, Mirai Foods AG
CALL FOR EXHIBITORS!
We invite all TEDD Partners and other companies to present their booth during our famous lunch break. The deadline for the exhibition call is 6 September 2021.
TEDD (Tissue Engineering for Drug Development and Substance Testing) is an education, R&D and networking platform promoting the application of 3D organotypic technologies, with the core goal of replacing animal experimentation for therapies development. Based in Switzerland, TEDD is one of its kind in Europe focused on 3D for 3Rs. The community is composed of international members from academia, clinics, industry and non-profits. Training of members is achieved through regular events at the national and international level, including workshops, symposia, company visits, scientific reviews and we provide a platform to generate research consortia, projects and grant applications.